A paradigm shift in the treatment of extreme prematurity: The artificial placenta

Current Opinion in Pediatrics

Volumn 26, Issue 3, 2014, Pages 370-376

  Davis, Ryan P ^a   Bryner, Benjamin ^a   Mychaliska, George B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Artificial placenta; ECLS; ECMO; ELGANs; prematurity

Indexed keywords

ARTIFICIAL ORGAN; ARTIFICIAL PLACENTA; DEVICE THERAPY; ELECTRONICS; EXTRACORPOREAL OXYGENATION; EXTREMELY LOW GESTATIONAL AGE NEWBORN; FETUS CIRCULATION; HUMAN; MICROCLIMATE; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL (TOPIC); PREMATURITY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING; ARTIFICIAL VENTILATION; FEMALE; GESTATIONAL AGE; NEWBORN; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

ARTIFICIAL ORGANS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; PLACENTA; PREGNANCY; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84900335241     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000083     Document Type: Review

References (47)

1. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100 (5 Pt 1):1020-1037
2. Boat AC, Sadhasivam S, Loepke AW, Kurth CD. Outcome for the extremely premature neonate: how far do we push the edge Paediatr Anaesth 2011; 21:765-770
3. Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126:443-456
4. Laughon MM, Langer JC, Bose CL, et al . Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med 2011; 183:1715-1722
5. Iacovidou N, Varsami M, Syggellou A. Neonatal outcome of preterm delivery. Ann N Y Acad Sci 2010; 1205:130-134
6. Hess JH. Experiences gained in a thirty year study of prematurely born infants. Pediatrics 1953; 11:425-434
7. Ballard PL, Granberg P, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Investig 1975; 56:1548-1554
8. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50:515-525
9. Kattner E, Metze B, Waiss E, Obladen M. Accelerated lung maturation following maternal steroid treatment in infants born before 30 weeks gestation. J Perinat Med 1992; 20:449-457
10. Wung JT, Koons AH, Driscoll JM Jr., James LS. Changing incidence of bronchopulmonary dysplasia. J Pediatr 1979; 95 (5 Pt 2):845-847
11. Bohn DJ, Miyasaka K, Marchak BE, et al. Ventilation by high-frequency oscillation. J Appl Physiol 1980; 48:710-716
12. Butler WJ, Bohn DJ, Bryan AC, Froese AB. Ventilation by high-frequency oscillation in humans. Anesth Analg 1980; 59:577-584
13. Cools F, Henderson-Smart DJ, Offringa M, Askie LM. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochr ane Database Syst Rev 2009; CD000104
14. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. Br Med J 1987; 294:991-996
15. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics 1988; 82:683-691
16. Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. N Engl J Med 1991; 325:1696-1703
17. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007; 196:147.e1-147.e8
18. Bartlett RH, Gazzaniga AB, Jefferies MR, et al. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 1976; 22:80-93
19. Cilley RE, Zwischenberger JB, Andrews AF, et al. Intracranial hemorrhage during extracorporeal membrane oxygenation in neonates. Pediatrics 1986; 78:699-704
20. Bartlett RH Andrews AF Toomasian JM et al. Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery 1982 92 425-433
21. Bartlett RH, Roloff DW, Cornell RG, et al. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 1985; 76:479-487
22. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989; 84:957-963
23. Kim A, Erickson K, Rana A, et al. Pushing the boundaries of ECLS: outcomes in 24.Van Meurs K, Zwischenberger JB, Extra corporeal Life Support Organization. ECMO: extracorporeal cardiopulmonary support in critical care. 3rd ed. Ann Arbor, Michigan: Extracorporeal Life Support Organization;2005
24. Van Meurs K, Zwischenberger JB, Extra corporeal Life Support Organization. ECMO: extracorporeal cardiopulmonary support in critical care. 3rd ed. Ann Arbor, Michigan: Extracorporeal Life Support Organization; 2005
25. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012; 38:210-220
26. Gray BW, Shaffer AW, Mychaliska GB. Advances in neonatal extracorporeal support: the role of extracorporeal membrane oxygenation and the artificial placenta. Clin Perinatol 2012; 39:311-329
27. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr 2001; 138:92-100
28. Parry G, Tucker J, Tarnow-Mordi W, Group UKNSSC. CRIB II: an update of the Clinical Risk Index for babies score. Lancet 2003; 361:1789-1791
29. Tyson JE, Parikh NA, Langer J, et al. Intensive care for extreme prematurity-moving beyond gestational age. N Engl J Med 2008; 358:1672-1681
30. Westin B, Nyberg R, Enhorning G. A technique for perfusion of the previable human fetus. Acta Paediatr 1958; 47:339-349
31. Callag han JC, Maynes EA, Hug HR. Studies on lambs of the development of an artificial placenta. Review of nine long-term survivors of extracorporeal circulation maintained in a fluid medium. Can J Surg 1965; 8:208-213
32. Zapol WM, Kolobow T, Pierce JG, Bowman RL. Artificial placenta: two days of total extrauterine support of the isolated premature lamb fetus. Science 1969; 166:617-618
33. Griff ith BP, Borovetz HS, Hardesty RL, et al. Arteriovenous ECMO for neonatal respiratory support. A study in perigestational lambs. J Thorac Cardiovasc Surg 1979; 77:595-601
34. Kuwabara Y, Okai T, Imanishi Y, et al. Development of extrauterine fetal incubation system using extracorporeal membrane oxygenator. Artif Organs 1987; 11:224-227
35. Kuwabar a Y, Okai T, Kozuma S, et al. Artificial placenta: long-term extrauterine incubation of isolated goat fetuses. Artif Organs 1989; 13:527-531
36. Unno N, Kuwabara Y, Okai T, et al. Development of an artificial placenta: survival of isolated goat fetuses for three weeks with umbilical arteriovenous extracorporeal membrane oxygenation. Artif Organs 1993; 17:996-1003
37. Yasufuku M, Hi sano K, Sakata M, Okada M. Arterio-venous extracorporeal membrane oxygenation of fetal goat incubated in artificial amniotic fluid (artificial placenta): influence on lung growth and maturation. J Pediatr Surg 1998; 33:44 2-448
38. Unno N, Kuwabara Y, Okai T, et al. Metabolic and endocrine responses to cold exposure in chronically incubated extrauterine goat fetuses. Pediatr Res 1998; 43 (4 Pt 1):452-460
39. Sakata M, Hisano K, Okada M, Yasufuku M. A new artificial placenta with a centrifugal pump: long-term total extrauterine support of goat fetuses. J Thorac Cardiovasc Surg 1998; 115:1023-1031
40. Kozuma S, Nishina H, Unno N, et al. Goat fetuses disconnected from the placenta, but reconnected to an artificial placenta, display intermittent breathing movements. Biol Neonate 1999; 75:388-397
41. Awad JA, Cloutier R, Fournier L, et al. Pumpless respiratory assistance using a membrane oxygenator as an artificial placenta: a preliminary study in newborn and preterm lambs. J Invest Surg 1995; 8: 21-30
42. Bartlett RH Andrews AF Toomasian JM et al. Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery 1982 92 425-433
43. Arens J, Schoberer M, Lohr A, et al. NeonatOx: a pumpless extracorporeal lung support for premature neonates. Artif Organs 2011; 35:997-1001
44. Miura Y, M atsuda T, Funakubo A, et al. Novel modification of an artificial placenta: pumpless arteriovenous extracorporeal life support in a premature lamb model. Pediatr Res 2012; 72:490-494
45. Seo T, Ito T, Iio K, et al. Experimental study on the hemodynamic effects of veno-arterial extracorporeal membrane oxygenation with an automatically driven blood pump on puppies. Artif Organs 1991; 15:402-407
46. Gray BW, El-Sabbagh A, Rojas-Pena A, et al. Development of an artificial placenta IV: 24 h venovenous extracorporeal life support in premature lambs. ASAIO J 2012; 58:148-154
47. Gray BW, El-Sabbagh A, Zakem SJ, et al. Development of an artificial placenta V: 70 h veno-venous extracorporeal life support after ventilatory failure in premature lambs. J Pediatr Surg 2013; 48:145-153.